Pfizer CEO Albert Bourla (Drew Angerer/Getty Images)
Pfizer, BioNTech say vaccine is 95% effective, EUA submission 'within days'
Pfizer and BioNTech have done the final efficacy analysis for their Phase III Covid-19 trial, and the results confirm the headline-grabbing release from last …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.